UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The New England journal of medicine, ISSN 0028-4793, 03/2015, Volume 372, Issue 11, pp. 1009 - 1018
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Single-Blind Method | Brain Ischemia - therapy | Humans | Middle Aged | Endovascular Procedures | Thrombectomy - instrumentation | Male | Combined Modality Therapy | Tissue Plasminogen Activator - therapeutic use | Angiography, Digital Subtraction | Reperfusion | Fibrinolytic Agents - therapeutic use | Carotid Artery, Internal - diagnostic imaging | Intention to Treat Analysis | Brain Ischemia - diagnosis | Female | Aged | Tomography, Emission-Computed | Perfusion Imaging | Stents | Stroke - therapy | Middle Cerebral Artery - diagnostic imaging | Stroke (Disease) | Usage | Care and treatment | Analysis | Outcome and process assessment (Health Care) | Risk factors | Endovascular stents | Neuroimaging | Cardiovascular system | Stroke | Territory | Medical imaging | Body weight | Clinical trials | Recovery of function | Hemorrhage | Computed tomography | Ischemia | Perfusion | Cerebral blood flow | Implants | Drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Stroke (1970), ISSN 0039-2499, 02/2020, Volume 51, Issue 2, pp. e21 - e23
Journal Article
Alzheimer's & dementia, ISSN 1552-5260, 12/2020, Volume 16, p. n/a
Journal Article
The New England journal of medicine, ISSN 0028-4793, 05/2019, Volume 380, Issue 19, pp. 1795 - 1803
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Brain - diagnostic imaging | Stroke - diagnostic imaging | Humans | Middle Aged | Male | Tissue Plasminogen Activator - therapeutic use | Tissue Plasminogen Activator - adverse effects | Fibrinolytic Agents - adverse effects | Nervous System Diseases - epidemiology | Fibrinolytic Agents - therapeutic use | Aged, 80 and over | Female | Stroke - mortality | Perfusion Imaging | Cerebral Hemorrhage - chemically induced | Time-to-Treatment | Magnetic Resonance Angiography | Stroke - drug therapy | Computed Tomography Angiography | Nervous System Diseases - prevention & control | Brain Ischemia - drug therapy | Aged | Infusions, Intravenous | Therapeutic Equipoise | Brain Ischemia - diagnostic imaging | Stroke (Disease) | Usage | Safety and security measures | Thrombolytic drugs | Drug therapy | Stroke patients | Health aspects | Intervention | Neuroimaging | Stroke | Neurosciences | Automation | Nuclear magnetic resonance--NMR | Intravenous administration | Medical imaging | Clinical trials | Hemorrhage | Patients | Thrombolysis | Evidence-based medicine | Intravenous therapy | Brain research | Sleep | Ischemia | Perfusion | Index Medicus | Abridged Index Medicus | Brain | Brain Ischemia | 80 and over | epidemiology | Neurologi | drug therapy | chemically induced | Cerebral Hemorrhage | Intravenous | Infusions | prevention & control | Fibrinolytic Agents | diagnostic imaging | Neurology | Tissue Plasminogen Activator | adverse effects | mortality | therapeutic use | Nervous System Diseases
Journal Article
The New England journal of medicine, ISSN 0028-4793, 04/2018, Volume 378, Issue 17, pp. 1573 - 1582
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cerebral Hemorrhage - chemically induced | Severity of Illness Index | Single-Blind Method | Time-to-Treatment | Humans | Middle Aged | Endovascular Procedures | Logistic Models | Male | Combined Modality Therapy | Stroke - drug therapy | Tissue Plasminogen Activator - therapeutic use | Tissue Plasminogen Activator - adverse effects | Fibrinolytic Agents - adverse effects | Stroke - surgery | Thrombectomy | Brain Ischemia - drug therapy | Fibrinolytic Agents - therapeutic use | Aged, 80 and over | Female | Aged | Reperfusion - methods | Stroke - mortality | Tenecteplase | Stroke (Disease) | Treatment outcome | Care and treatment | Tissue plasminogen activator | Analysis | Dosage and administration | Research | Comparative analysis | Reperfusion injury | Cardiovascular system | Stroke | Territory | Intravenous administration | Medical imaging | Body weight | Thrombosis | Hemorrhage | Thrombolysis | Carotid arteries | Fibrin | Neurology | Brain research | Reperfusion | Ischemia | Consent | Cerebral blood flow | Drug dosages | Veins & arteries | Index Medicus | Abridged Index Medicus
Journal Article
International psychogeriatrics, ISSN 1041-6102, 10/2020, Volume 32, Issue S1, pp. 73 - 73
Journal Article
Journal of Alzheimer's disease, ISSN 1387-2877, 01/2019, Volume 68, Issue 3, pp. 1211 - 1228
Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Brain | Middle age | Websites | Modules | Cognitive ability | Health risks | Risk assessment | Genetic analysis | Dementia disorders | Genetics | Adults | Internet | Saliva | Alzheimer's disease | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 07/2019, Volume 394, Issue 10193, pp. 139 - 147
Cerebral Hemorrhage - chemically induced | Stroke - diagnostic imaging | Time-to-Treatment | Humans | Tomography, X-Ray Computed | Treatment Outcome | Stroke - drug therapy | Tissue Plasminogen Activator - therapeutic use | Tissue Plasminogen Activator - adverse effects | Fibrinolytic Agents - adverse effects | Brain Ischemia - drug therapy | Fibrinolytic Agents - therapeutic use | Diffusion Magnetic Resonance Imaging | Thrombolytic Therapy - methods | Perfusion Imaging | Brain Ischemia - diagnostic imaging | Neuroimaging | Brain | Signs and symptoms | Stroke | Automation | Medical imaging | Adjustment | Clinical trials | Systematic review | Regression analysis | Hemorrhage | Patients | Thrombolysis | Evidence-based medicine | Meta-analysis | Intravenous therapy | Regression models | Magnetic resonance imaging | Computed tomography | Perfusion | Software | Neurologi | Brain Ischemia | drug therapy | chemically induced | Cerebral Hemorrhage | X-Ray Computed | methods | Fibrinolytic Agents | diagnostic imaging | Neurology | Tissue Plasminogen Activator | Thrombolytic Therapy | adverse effects | Tomography | therapeutic use
Journal Article
Nature biotechnology, ISSN 1087-0156, 03/2016, Volume 34, Issue 3, pp. 320 - 327
Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Science & Technology | Electrodes | Motor Cortex - physiology | Animals | Humans | Neurons - physiology | Endovascular Procedures | Sheep | Cerebral Angiography - methods | Stents | Catheters | Usage | Design and construction | Brain stimulation | Methods | Brain mapping | Endovascular stents | Brain | Electroencephalography | Neurobiology | Biomedical engineering | Index Medicus
Journal Article
International psychogeriatrics, ISSN 1041-6102, 10/2020, Volume 32, Issue S1, pp. 74 - 74
Journal Article